The Effect of Accessory Pathway Location on Cardiac Function in Adult Patients with Wolff–Parkinson–White Syndrome
Table 1
Baseline characteristics of the study population.
Parameter
Septal
Right free wall
Left free wall
Concealed
Age (years)
36 ± 16
43 ± 14
43 ± 15
43 ± 12
0.32
Female
6 (30)
7 (35)
7 (35)
9 (45)
0.795
Wt (kg)
66 ± 9
69 ± 8
69 ± 7
67 ± 10
0.566
HR (beats/min)
69 ± 10
71 ± 14
65 ± 12
74 ± 13
0.157
BUN (μmol/l)
5.78 ± 1.43
5.25 ± 1.59
5.01 ± 1.69
5.24 ± 1.21
0.413
Cr (μmol/l)
62.4 ± 14
70.5 ± 14.6
66.8 ± 16.7
62.4 ± 14.8
0.267
eGFR (ml/min/1.73 m2)
117.5 ± 17.6
107.3 ± 16.1
109.1 ± 12.5
105.2 ± 26.7
0.189
Hs-CRP (μmol/l)
1.16 ± 2.22
1.01 ± 1.25
1.35 ± 2.88
0.51 ± 0.52
0.553
Cys C (μmol/l)
0.79 ± 0.18
0.77 ± 0.18
0.86 ± 0.14
0.77 ± 0.16
0.265
NT-proBNP (ng/ml)
159 ± 241#
132 ± 129#
58 ± 66
48 ± 40
0.039
Data are given as mean ± SD or n (%). P refers to comparison between the four groups. . vs. concealed. Wt: weight; HR: heart rate; BUN: blood urea nitrogen; Cr: creatinine; eGFR: estimated glomerular filtration rate, hs-CRP: high-sensitivity C-reactive protein; Cys C: cystatin C; NT-proBNP: N-terminal pro-B-type natriuretic peptide.
